title: Galenic formulations and Helicobacter pylori eradication.
authors.forename: D
authors.initials: D
authors.lastname: Boixeda
authors.forename: C
authors.initials: C
authors.lastname: Martin-de-Argila
authors.forename: R
authors.initials: R
authors.lastname: Cantón
authors.forename: L
authors.initials: L
authors.lastname: de Rafael
authors.forename: F
authors.initials: F
authors.lastname: Baquero
mesh_terms: D000658:Amoxicillin / Q000008:administration & dosage*; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D002214:Capsules; D019818:Clavulanic Acid; D002969:Clavulanic Acids / Q000008:administration & dosage*; D004359:Drug Therapy, Combination / Q000008:administration & dosage*; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans; D010406:Penicillins / Q000008:administration & dosage*; D013535:Suspensions
chemical_list: D000900:Anti-Bacterial Agents; D002214:Capsules; D002969:Clavulanic Acids; D010406:Penicillins; D013535:Suspensions; D019818:Clavulanic Acid; D000658:Amoxicillin